Sort   by:  
 Page size 
UnknownComparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE.

Background

Low-molecular-weight heparins (LMWHs) are widely used in the treatment of cancer-associated venous thromboembolism (VTE), yet their long-term safety profiles remain insufficiently compared in clinical practice.

Objectives

The primary outcome was major bleeding over a 6-mont...
S-EPMC12681984 | biostudies-literature
UnknownCOVID-19-associated venous thromboembolism: risk of recurrence and major bleeding.

Background

Complications under anticoagulant treatment in patients with COVID-19-associated venous thromboembolism (VTE) have not been consistently reported.

Objectives

This study aimed to compare the 90-day rates of VTE recurrences and major bleeding in patients with COVID-19-associa...
S-EPMC10569976 | biostudies-literature
UnknownRisk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study.

Background

The clinical relevance of recurrent venous thromboembolism (VTE) after discontinuing anticoagulation in patients with COVID-19-associated VTE remains uncertain. We estimated the incidence rates and mortality of VTE recurrences developing after discontinuing anticoagulation in pati...
S-EPMC11139764 | biostudies-literature
UnknownClinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.

Importance

Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, thrombosis in infrapopliteal veins without proximal extension or pulmonary embolism (PE).

Objective

To determi...
S-EPMC9280612 | biostudies-literature
Sort   by:  
 Page size